Literature DB >> 10150155

Cost, benefits and unintended gastrointestinal side effects of pharmaceutical therapy.

B S Bloom1.   

Abstract

All healthcare services, however beneficial, carry inherent risks in addition to the costs of care, which may involve expenditures on unanticipated side effects. Substantial research over the past few decades has elucidated the full range of clinical and resource use effects of peptic ulcer medications, particularly for histamine H 2-receptor antagonists and nonsteroidal anti-inflammatory drug (NSAID)-related gastropathy. Less well known are some of the positive and negative side effects of many different types of pharmaceuticals on the gastrointestinal tract. This paper summarises information on unintended and unexpected positive and negative gastrointestinal side effects of medications administered to treat gastrointestinal and other diseases. It further analyses 2 drug classes and their effects on the gastrointestinal tract, histamine H 2-receptor antagonists, which have a positive impact on clinical effects and resource use, and NSAIDs, which have negative effects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 10150155     DOI: 10.2165/00019053-199201030-00004

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  31 in total

1.  Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate.

Authors:  R Kochhar; F Patel; A Dhar; S C Sharma; S Ayyagari; R Aggarwal; M K Goenka; B D Gupta; S K Mehta
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

2.  Increased risk of cholecystectomy in users of supplemental estrogen.

Authors:  D B Petitti; S Sidney; J A Perlman
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

3.  The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding.

Authors:  J L Carson; B L Strom; K A Soper; S L West; M L Morse
Journal:  Arch Intern Med       Date:  1987-01

4.  Current peptic ulcer time trends. An epidemiological profile.

Authors:  J H Kurata; E D Corboy
Journal:  J Clin Gastroenterol       Date:  1988-06       Impact factor: 3.062

5.  Non-steroidal anti-inflammatory drugs and peptic ulcer perforation.

Authors:  D S Collier; J A Pain
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

Review 6.  Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development.

Authors:  M A Peppercorn
Journal:  Ann Intern Med       Date:  1984-09       Impact factor: 25.391

7.  Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons.

Authors:  M R Griffin; J M Piper; J R Daugherty; M Snowden; W A Ray
Journal:  Ann Intern Med       Date:  1991-02-15       Impact factor: 25.391

8.  Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.

Authors:  R S Ehsanullah; M C Page; G Tildesley; J R Wood
Journal:  BMJ       Date:  1988-10-22

9.  Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983.

Authors:  H A Guess; R West; L M Strand; D Helston; E G Lydick; U Bergman; K Wolski
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

10.  Biliary colic treatment and acute cholecystitis prevention by prostaglandin inhibitor.

Authors:  G Goldman; P J Kahn; R Alon; T Wiznitzer
Journal:  Dig Dis Sci       Date:  1989-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.